DeCure's autonomous Nephrology AI scientist is researching a drug-repurposing hypothesis for karyomegalic interstitial nephritis — screening already-approved drugs against its 2-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleKaryomegalic interstitial nephritis maps to a 2-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for karyomegalic interstitial nephritis is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
FANCD2 and FANCI associated nuclease 1 (FAN1) — FAN1 is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet apo structuredrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 9GY0 · 3.42 Å · ligand none (apo structure). Experimental structure, not a prediction.
What the evidence adds up to
Karyomegalic interstitial nephritis is a rare chronic interstitial nephritis, with fewer than 50 cases reported in the English literature as of 2021. It is characterised by enlarged, hyperchromatic nuclei in scattered tubular epithelial cells throughout the nephron, accompanied by interstitial fibrosis around atrophic tubules. The condition is strongly suspected to have a genetic background, and a family history of chronic interstitial nephritis has been noted. Renal biopsy is the gold standard for diagnosis, and karyomegalic changes have also been found in skin, duodenal, and liver biopsies, as well as in urine cells and, in one autopsy, in brain, thyroid, lung, oesophagus, and arteries.
The disease usually presents with slowly progressive chronic kidney disease that eventually leads to end-stage renal disease in early adulthood. In a 2006 series of three new cases, one patient did not yet require dialysis at the time of reporting, while two siblings required dialysis 4 years and 1 year after diagnosis respectively, and both died. A 2020 case report described a patient with KIN who also had nephrotic syndrome and focal and segmental glomerulosclerosis, the second such association reported from India. A 2021 case series of five patients from Pakistan described the disease as having an escalated course with a worsened outcome.
The literature consistently states that KIN remains underdiagnosed. A high index of clinical suspicion is necessary to perform the renal biopsy that confirms the diagnosis. What is still missing is any systematic study of treatments or interventions that might alter the course of the disease; no drug therapy is mentioned in these reports. There are no prospective trials, no data on patient stratification by genetic mutation, and no funding directed at understanding or slowing progression to end-stage renal disease.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Clinical Nephrology · 2006 · 29 citations
Karyomegalic interstitial nephritis: report of 3 new cases and review of the literature
AbstractKaryomegalic interstitial nephritis is a rare, but perhaps an "underdiagnosed" condition. Peculiar nuclear changes characterize it, involving mainly tubular cells along with glomeruli and blood vessels. Herein, 3 bioptically proven new cases of patients with chronic renal failure are discussed. The first case had a recently diagnosed karyomegalic nephritis which, to date, still does not require dialysis. The other 2 (brother and sister) required dialysis 4 and 1 years after diagnosis. Karyomegalic changes were found not only in the skin and duodenal biopsies of the male, in skin and liver biopsies of the female and in the urine cells of both patients, but also in several organs (brain, thyroid, lung, esophagus, arteries) as shown at the autopsy of the female. There was a fatal outcome for both patients. The data reported in this study emphasize the usefulness of pathologic investigation of both tissue and urine samples in the identification of this disease. Moreover, as karyomegalic interstitial nephritis is strongly suspected to have a genetic background, its identification may well not only be of clinical relevance, due to its ominous outcome, but may also bear eugenetic value.
Journal of medical case reports and reviews · 2020 · 2 citations · open access
A RARE CASE REPORT OF KARYOMEGALIC INTERSTITIAL NEPHRITIS WITH FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS
AbstractKaryomegalic interstitial nephritis (KIN) is a rare form of progressive chronic interstitial nephritis. We present a case of KIN in an adult, who also have nephrotic syndrome. Only one case has been reported of KIN associated with FSGS in the literature. Our case also exhibited similar condition with focal and segmental glomerulosclerosis with KIN, which was second association reported from India.
Surgical and Experimental Pathology · 2021 · 2 citations · open access
Karyomegalic interstitial nephritis: diagnosed only when suspected
AbstractAbstract Background Karyomegalic interstitial nephritis (KIN) is an uncommon cause of chronic interstitial nephritis that eventually progresses to end-stage renal disease. Overall less than 50 cases have been reported in the literature. Case presentation We describe an asymptomatic 25-year-old gentleman with a family history of chronic interstitial nephritis who came to check the status of his kidney functions. On evaluation, he was found to have chronic interstitial nephritis which could not be attributed to a specific etiology. Renal biopsy confirmed the diagnosis of KIN. Conclusion KIN remains underdiagnosed. It is important to recognize this entity because of the familial nature, a wide range of differential diagnoses, and prognostic implications. A high index of clinical suspicion is necessary to perform renal biopsy which remains the gold standard for the diagnosis of KIN.
Karyomegalic Interstitial Nephritis-A Rare Cause Of Chronic Tubulointerstitial Nephritis
AbstractKaryomegalic Interstitial Nephritis (KIN) is a rare disease, which usually presents with slowly progressive chronic kidney disease, eventually leading to end stage renal disease in early adulthood. Histological findings consist of enlarged and hyperchromatic nuclei in scattered tubular epithelial cells throughout the nephron accompanied by interstitial fibrosis around atrophic tubules.
American Journal of Medical Case Reports · 2021 · 0 citations · open access
Karyomegalic Interstitial Nephritis: Case Series and Review of Literature
AbstractKaryomegalic interstitial nephritis (KIN) is a rare cause of hereditary interstitial nephritis, described 45 years ago. Only about 50 cases have been described in English literature so far and none from Pakistan. This disease has an escalated course with a worsened outcome. There are a few potential mimickers of this disease both clinically and histologically, which might lead to a missed diagnosis and hence poor management. We have described here a series of 05 cases of KIN that were diagnosed at our institute for better understanding of this disease entity.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
